The survival analysis further suggested the regulatory correlation: elevated FAM18A-AS1 and miR-21 were associated with poor prognosis in glioma, and low expression of BCL7A, SATB1, and CPEB3 was associated with favorable prognosis. This evidence concerns the gene CPEB3 and central nervous system cancer.